Methadone Maintenance in Primary Care: A Randomized Controlled Trial
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
CONTEXT: Methadone maintenance is an effective treatment for opioid dependence, yet its use is restricted to federally licensed narcotic treatment programs (NTPs). Office-based care of stabilized methadone maintenance patients is a promising alternative but no data are available from controlled trials regarding this type of program. OBJECTIVE: To determine the feasibility and efficacy of office-based methadone maintenance by primary care physicians vs in an NTP for stable opioid-dependent patients. DESIGN: Six-month, randomized controlled open clinical trial conducted February 1999-March 2000. SETTING: Offices of 6 primary care internists and an NTP. PATIENTS: Forty-seven opioid-dependent patients who had been receiving methadone maintenance therapy in an NTP without evidence of illicit drug use for 1 year and without significant untreated psychiatric comorbidity were randomized; 1 patient refused to participate after treatment assignment to NTP. INTERVENTIONS: Patients were randomly assigned to receive office-based methadone maintenance from primary care physicians, who received specialized training in the care of opioid-dependent patients (n = 22), or usual care at an NTP (n = 24). MAIN OUTCOME MEASURES: Illicit drug use, clinical instability (persistent drug use), patient and clinician satisfaction, functional status, and use of health, legal, and social services, compared between the 2 groups. RESULTS: Eleven of 22 (50%; 95% confidence interval [CI], 29%-71%) patients in office-based care compared with 9 of 24 (38%; 95% CI, 21%-57%) of NTP patients had a self-report or urine toxicology test result indicating illicit opiate use (P =.39). Hair toxicology testing detected an additional 2 patients in each treatment group with evidence of illicit drug use, but this did not change the overall findings. Ongoing illicit drug use meeting criteria for clinical instability occurred in 4 of 22 (18%; 95% CI, 7%-39%) patients in office-based care compared with 5 of 24 (21%; 95% CI, 9%-41%) NTP patients (P =.82). Sixteen of the 22 (73%; 95% CI, 54%-92%) office-based patients compared with 3 of the 24 (13%; 95% CI, 0%-26%) NTP patients thought the quality of care was excellent (P =.001). There were no differences over time within or between groups in functional status or use of health, legal, or social services. CONCLUSIONS: Our results support the feasibility and efficacy of transferring stable opioid-dependent patients receiving methadone maintenance to primary care physicians' offices for continuing treatment and suggest guidelines for identifying patients and clinical monitoring.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Power Analysis for the Behavioral Sciences
Muller, K. (1989) · Technometrics · doi:10.1080/00401706.1989.10488618 · Cited by 99,167
Statistical power analysis for the behavioral sciences
(1990) · Computers, Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,269
The CES-D Scale: A Self-Report Depression Scale for Research in the General Population
Radloff, L. S. (1977) · Applied Psychological Measurement · doi:10.1177/014662167700100306 · Cited by 53,267 · cited 6×
“(%) [95% CI] 8 (36) [20-57] 9 (38) [21-57] .”
BackgroundInfluentialStatistical Power Analysis for the Behavioral Sciences (2nd ed.).
Lachenbruch, P. A., & Cohen, J. (1989) · Journal of the American Statistical Association · doi:10.2307/2290095 · Cited by 37,395
(1992) · PubMed · Cited by 33,716
The fifth edition of the addiction severity index
McLellan, A. T., Kushner, H., Metzger, D., Peters, R., Smith, I., Grissom, G., Pettinati, H., & Argeriou, M. (1992) · Journal of Substance Abuse Treatment · doi:10.1016/0740-5472(92)90062-s · Cited by 4,222 · cited 6×
“(%) [95% CI] 8 (36) [20-57] 9 (38) [21-57] .”
BackgroundInfluentialThe Effectiveness of Methadone Maintenance Treatment: Patients, Programs, Services, and Outcome
Ball, J. C., & Ross, A. O. (1991) · Cited by 903
Psychiatric and Substance Use Comorbidity Among Treatment-Seeking Opioid Abusers
Brooner, R. K. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830130077015 · Cited by 746
Overview of 1-year follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS).
Hubbard, R. L., Craddock, S. G., Flynn, P. M., Anderson, J., & Etheridge, R. M. (1997) · Psychology of Addictive Behaviors · doi:10.1037//0893-164x.11.4.261 · Cited by 602
The Effectiveness of Methadone Maintenance Treatment
Ball, J. C., & Ross, A. (1991) · Springer eBooks · doi:10.1007/978-1-4613-9089-3 · Cited by 590 · cited 3×
“Urine test with evidence of cocaine use 9/251 (4) [2-6] 15/369 (4) [2-6] .”
BackgroundEffective Medical Treatment of Opiate Addiction
Addiction, N. C. D. P. O. E. M. T. O. O. (1998) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.280.22.1936 · Cited by 577
Metzger, D. S., WOODY, G. E., McLellan, A. T., O’Brien, C. P., Druley, P., Navaline, H. A., DePhilippis, D., Stolley, P. D., & Abrutyn, E. (1993) · PubMed · Cited by 530
Subverting Randomization in Controlled Trials
Schulz, K. F. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530180050029 · Cited by 516 · cited 6×
“(%) [95% CI] 8 (36) [20-57] 9 (38) [21-57] .”
BackgroundInfluentialHair Analysis for Drugs of Abuse
Baumgartner, W., Hill, V., & Blahd, W. (1989) · Journal of Forensic Sciences · doi:10.1520/jfs12787j · Cited by 472
Office of National Drug Control Policy
(2004) · Encyclopedia of Law Enforcement · doi:10.4135/9781412952415.n342 · Cited by 416
Sees, K. L., Delucchi, K. L., Masson, C., Rosen, A., Clark, H. W., Robillard, H., Banys, P., & Hall, S. M. (2000) · JAMA · doi:10.1001/jama.283.10.1303 · Cited by 415 · cited 6×
“(%) [95% CI] 8 (36) [20-57] 9 (38) [21-57] .”
BackgroundInfluentialPsychotherapy and Pharmacotherapy for Ambulatory Cocaine Abusers
Carroll, K. M. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030013002 · Cited by 348
Statistical power analysis : a computer program
Cohen, J., & Borenstein, M. (1988) · Lawrence Erlbaum Associates eBooks · Cited by 269
Drug abuse treatment as AIDS prevention.
Metzger, D. S., Navaline, H. A., & WOODY, G. E. (1998) · Europe PMC (PubMed Central) · Cited by 221
Pharmacologic Treatment of Heroin-Dependent Patients
O'Connor, P. G., & Fiellin, D. A. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-1-200007040-00008 · Cited by 183 · cited 4×
“Urine test with evidence of illicit opiate use 22/252 (9) [6-13] 41/370 (11) [8-14] .”
BackgroundInfluentialSelf-citationFederal Regulation of Methadone Treatment
Rettig, R. A., & Yarmolinsky, A. (1995) · Cited by 175
O’Connor, P., Oliveto, A., Shi, J., Triffleman, E., Carroll, K., Kosten, T., Rounsaville, B., Pakes, J., & Schottenfeld, R. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00194-6 · Cited by 174 · cited 6×
“(%) [95% CI] 8 (36) [20-57] 9 (38) [21-57] .”
BackgroundInfluentialSelf-citationHeroin use during methadone maintenance treatment: the importance of methadone dose and cocaine use.
Hartel, D. M., Schoenbaum, E. E., Selwyn, P. A., Kline, J., Davenny, K., Klein, R. S., & Friedland, G. H. (1995) · American Journal of Public Health · doi:10.2105/ajph.85.1.83 · Cited by 169 · cited 5×
“(%) [95% CI] 8 (36) [20-57] 9 (38) [21-57] .”
BackgroundInfluentialDetecting Selection Bias in Randomized Clinical Trials
Berger, V. W., & Exner, D. V. (1999) · Controlled Clinical Trials · doi:10.1016/s0197-2456(99)00014-8 · Cited by 163 · cited 6×
“(%) [95% CI] 8 (36) [20-57] 9 (38) [21-57] .”
BackgroundInfluentialMethadone Treatment and Acquired Immunodeficiency Syndrome
Cooper, J. R. (1989) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1989.03430120118033 · Cited by 156 · cited 4×
“Urine test with evidence of illicit opiate use 22/252 (9) [6-13] 41/370 (11) [8-14] .”
BackgroundInfluentialMethadone maintenance patients in general medical practice. A preliminary report
Novick, D. M. (1988) · JAMA · doi:10.1001/jama.259.22.3299 · Cited by 73
Weinrich, M., & Stuart, M. (2000) · JAMA · doi:10.1001/jama.283.10.1343 · Cited by 70 · cited 7×
“(%) [95% CI] 8 (36) [20-57] 9 (38) [21-57] .”
BackgroundInfluentialA 12‐Year Follow‐Up of a Methadone Medical Maintenance Program
Schwartz, R. P., Brooner, R. K., Montoya, I. D., Currens, M., & Hayes, M. (1999) · The American Journal on Addictions · doi:10.1080/105504999305695 · Cited by 70 · cited 3×
“Patients with evidence of cocaine use 4 (18) [3-33] 4 (17) [2-30] .”
BackgroundPHARMACOTHERAPY FOR OPIOID AND COCAINE ABUSE
Warner, E. A., Kosten, T. R., & O’Connor, P. G. (1997) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70555-1 · Cited by 69 · cited 6×
“(%) [95% CI] 8 (36) [20-57] 9 (38) [21-57] .”
BackgroundInfluentialSelf-citationNovick, D. M., Joseph, H., Salsitz, E. A., Kalin, M. F., Keefe, J. B., Miller, E. L., & Richman, B. L. (1994) · Journal of General Internal Medicine · doi:10.1007/bf02600025 · Cited by 65
Salsitz, E. A., Joseph, H., Frank, B., Perez, J., Richman, B. L., Salomon, N., Kalin, M. F., & Novick, D. M. (2000) · PubMed · Cited by 57
Methadone treatment and acquired immunodeficiency syndrome
Cooper, J. R. (1989) · JAMA · doi:10.1001/jama.262.12.1664 · Cited by 51
French general practitioners' attitudes toward maintenance drug abuse treatment with buprenorphine
Moatti, J., Souville, M., Escaffre, N., & Obadia, Y. (1998) · Addiction · doi:10.1046/j.1360-0443.1998.9310156714.x · Cited by 51 · cited 6×
“(%) [95% CI] 8 (36) [20-57] 9 (38) [21-57] .”
BackgroundInfluentialLewis, D. C. (1999) · Journal of Addictive Diseases · doi:10.1300/j069v18n02_02 · Cited by 48 · cited 7×
“(%) [95% CI] 8 (36) [20-57] 9 (38) [21-57] .”
BackgroundInfluentialIncluding Narcotic Addiction Treatment in an Office-Based Practice
Cooper, J. R. (1995) · JAMA · doi:10.1001/jama.1995.03520440073040 · Cited by 44 · cited 4×
“Urine test with evidence of illicit opiate use 22/252 (9) [6-13] 41/370 (11) [8-14] .”
BackgroundInfluentialSenay, E. C., Barthwell, A. G., Marks, R., Bokos, P. J., Gillman, D., White, R., & Pristach, C. A. (1993) · Journal of Addictive Diseases · doi:10.1300/j069v12n04_05 · Cited by 30 · cited 4×
“Urine test with evidence of illicit opiate use 22/252 (9) [6-13] 41/370 (11) [8-14] .”
BackgroundInfluentialZanis, D. A., McLellan, A. T., Belding, M. A., & Moyer, G. (1997) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(97)00135-x · Cited by 22 · cited 6×
“(%) [95% CI] 8 (36) [20-57] 9 (38) [21-57] .”
BackgroundInfluential&NA; (2001) · Survey of Anesthesiology · doi:10.1097/00132586-200104000-00058 · Cited by 19
Stimmel, B. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102153440715 · Cited by 3
Parrino, M. W. (1998) · Journal of Maintenance in the Addictions · doi:10.1300/j126v01n03_09 · Cited by 3 · cited 6×
“(%) [95% CI] 8 (36) [20-57] 9 (38) [21-57] .”
BackgroundInfluential
Cited by
Connock, M., Juarez-Garcia, A., Jowett, S., Frew, E., Liu, Z., Taylor, R., Fry-Smith, A., Day, E., Lintzeris, N., Roberts, T., et al. (2007) · Health Technology Assessment · doi:10.3310/hta11090 · Cited by 585
Medication-Assisted Treatment of Opioid Use Disorder: Review of the Evidence and Future Directions
Connery, H. S. (2015) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000075 · Cited by 576
Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence
Uchtenhagen, A. (2009) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-17408 · Cited by 490
Counseling plus Buprenorphine–Naloxone Maintenance Therapy for Opioid Dependence
Fiellin, D. A., Pantalon, M. V., Chawarski, M. C., Moore, B. A., Sullivan, L. E., O'Connor, P. G., & Schottenfeld, R. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055255 · Cited by 351
Self-citationMutual Mistrust in the Medical Care of Drug Users. The Keys to the "Narc" Cabinet
Merrill, J. O., Rhodes, L. A., Deyo, R. A., Marlatt, G. A., & Bradley, K. A. (2002) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2002.10625.x · Cited by 296
Metadata
- Authors
- Fiellin, D. A., O'Connor, P. G., Chawarski, M., Pakes, J. P., Pantalon, M. V., & Schottenfeld, R. S.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2001-10-10
- Volume
- 286
- Issue
- 14
- Pages
- 1724
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2023468678
- Cited by
- 182
- References
- 40
- FWCI
- 11.81
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.